# Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg

> **NCT02485028** · PHASE1 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** Dapoxetine 30mg tablet
- **DRUG:** Mirodenafil 50mg tablet

## Key facts

- **NCT ID:** NCT02485028
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02485028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02485028, "Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mg". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02485028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*